| Literature DB >> 31712650 |
Irengbam Rocky Mangangcha1,2,3,4, Md Zubbair Malik4, Ömer Küçük5, Shakir Ali6,7, R K Brojen Singh8.
Abstract
Identification of key regulators and regulatory pathways is an important step in the discovery of genes involved in cancer. Here, we propose a method to identify key regulators in prostate cancer (PCa) from a network constructed from gene expression datasets of PCa patients. Overexpressed genes were identified using BioXpress, having a mutational status according to COSMIC, followed by the construction of PCa Interactome network using the curated genes. The topological parameters of the network exhibited power law nature indicating hierarchical scale-free properties and five levels of organization. Highest degree hubs (k ≥ 65) were selected from the PCa network, traced, and 19 of them was identified as novel key regulators, as they participated at all network levels serving as backbone. Of the 19 hubs, some have been reported in literature to be associated with PCa and other cancers. Based on participation coefficient values most of these are connector or kinless hubs suggesting significant roles in modular linkage. The observation of non-monotonicity in the rich club formation suggested the importance of intermediate hubs in network integration, and they may play crucial roles in network stabilization. The network was self-organized as evident from fractal nature in topological parameters of it and lacked a central control mechanism.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31712650 PMCID: PMC6848149 DOI: 10.1038/s41598-019-52896-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flowchart of the methodology.
Figure 2Topological properties of PCa and the modules/communities at the first hierarchical level. Degree distribution probability (P(k)), clustering coefficient (C(k)), neighbourhood connectivity (C(K)) as function of degree (k) and centrality measurement closeness (C(k)), betweenness centrality (C(k)), eigenvector centrality ((C(k)), subgraph centrality (C) as a function of degree.
Figure 3(A) Communities/modules of PCa PPI network. (B) Interacting partners of the 19 key regulators at motif level. (C) Protein Protein Interaction of key regulators with AR through TP53, CTNNB1 and AKT1 constructed from GeneMANIA.
Key regulators and their topological properties.
| Sl. No. | ID | Gene | Function | Degree | Closeness centrality | Betweenness centrality | Eigenvector centrality | Subgraph centrality |
|---|---|---|---|---|---|---|---|---|
| 1 |
| Activator of Hsp90 ATPase activity 1 | Positive regulation of ATPase | 75 | 0.379262 | 0.00331 | 0.054588 | 2.47E + 23 |
| 2 |
| Chaperonin containing TCP1 subunit 4 | Protein folding | 66 | 0.384435 | 0.003334 | 0.033523 | 9.29E + 22 |
| 3 |
| Cullin 7 | Ubiquitin-dependent protein catabolism | 270 | 0.435916 | 0.034463 | 0.151248 | 1.89E + 24 |
| 4 |
| Eukaryotic translation initiation factor 3 subunit A | Translation pre-initiation complex formation | 85 | 0.37006 | 0.002209 | 0.079073 | 5.18E + 23 |
| 5 |
| Heat shock protein family A (Hsp70) member 5 | Activation of signaling protein activity involved in unfolded protein response | 111 | 0.408758 | 0.012349 | 0.062591 | 3.24E + 23 |
| 6 |
| NOP2 nucleolar protein | rRNA base methylation, | 68 | 0.375317 | 0.001319 | 0.076741 | 4.88E + 23 |
| 7 |
| RAN binding protein 2 | Protein sumoylation | 72 | 0.386242 | 0.004881 | 0.031476 | 8.19E + 22 |
| 8 |
| Ribosomal protein L11 | Ribosomal large subunit assembly | 83 | 0.383638 | 0.001239 | 0.114333 | 1.08E + 24 |
| 9 |
| Ribosomal protein L15 | Nuclear-transcribed mRNA catabolic process | 79 | 0.382201 | 0.001289 | 0.109354 | 9.91E + 23 |
| 10 |
| Ribosomal protein L19 | Nuclear-transcribed mRNA catabolic process | 78 | 0.381856 | 0.000469 | 0.113259 | 1.06E + 24 |
| 11 |
| Ribosomal protein L23a | Ribosomal large subunit assembly | 84 | 0.379602 | 0.001182 | 0.109817 | 9.99E + 23 |
| 12 |
| Ribosomal protein L3 | Ribosomal large subunit assembly | 67 | 0.385588 | 0.000788 | 0.100707 | 8.41E + 23 |
| 13 |
| Ribosomal protein L5 | Ribosomal large subunit assembly | 92 | 0.383141 | 0.001438 | 0.114815 | 1.09E + 24 |
| 14 |
| Ribosomal protein L6 | Ribosomal large subunit assembly | 113 | 0.39809 | 0.003601 | 0.129049 | 1.38E + 24 |
| 15 |
| Ribosomal protein lateral stalk subunit P0 | Nuclear-transcribed mRNA catabolic process | 88 | 0.394955 | 0.002486 | 0.110764 | 1.02E + 24 |
| 16 |
| Ribosomal protein S11 | Nuclear-transcribed mRNA catabolic process | 74 | 0.376943 | 0.000751 | 0.102129 | 8.64E + 23 |
| 17 |
| Ribosomal protein S8 | Nuclear-transcribed mRNA catabolic process | 120 | 0.394218 | 0.004481 | 0.126136 | 1.32E + 24 |
| 18 |
| Ribosomal protein SA | Ribosomal small subunit assembly | 79 | 0.378002 | 0.002864 | 0.094957 | 7.47E + 23 |
| 19 |
| SNU13 homolog, small nuclear ribonucleoprotein (U4/U6, U5) | mRNA splicing, via spliceosome | 87 | 0.370245 | 0.003088 | 0.072649 | 4.37E + 23 |
The key regulator identified in this study and their key functions in disease conditions.
| Genes | Function/mechanism | Condition/Disease | Reference |
|---|---|---|---|
|
| |||
| Stabilizes p53/TAp73 (by binding to the MDM2/MDMX/HDM2) and inhibits ubiquitination of p53/TAp73 | Arrests cell growth arrest, promote apoptosis |
[ |
|
| Stabilizes p53 and inhibits RAS-mediated tumorigenesis | Arrests cell growth arrest, promote apoptosis |
[ |
|
| Either prevents the binding of co-activator TRRAP to | Inactivates |
[ |
|
| Upregulates Cyclin E, promoting cell growth and cell cycle progression; inhibition is reported to downregulate Cyclin E, arresting cell cycle at G1 | Gastric cancer and Multi drug resistance gastric cancer |
[ |
|
| Overexpression | Pancreatic ductal carcinoma, gastric, colorectal, breast and oral cancers |
[ |
|
| The gene product RPLP0 interacts with Cathepsin X; knockdown arrests cell cycle at G1, increasing apoptosis | Gastric, ovarian and endometrial cancers |
[ |
|
| A cell surface receptor (binding to lamin), facilitates cell adhesion and activation of signal transduction pathways; overexpression linked to tumor aggression and metastasis | Colorectal cancer |
[ |
| Overexpression. RPL19 overexpression serve as a Prognostic marker in PCa | Glioblastoma, colorectal, gastric, lung, and prostate cancers |
[ | |
|
| |||
|
| Interacts with several RPs | Strengthens the role of RPs |
[ |
|
| Mutated | Hereditary sensory neuropathy |
[ |
|
| Wnt/β-catenin signaling pathway | Cell growth, apoptosis, migration and invasion |
[ |
|
| ERK-SNAI2 signalling, affecting cell adhesion inhibition of p53; Cyclin A overexpression and affecting microtubule dynamics by increasing α-tubulin accumulation | Epithelial-mesenchymal transition in metastasis, inhibits apoptosis, cycle progression, cell proliferation and migration lung, breast cancer |
[ |
|
| Translation initiation and regulation of mTOR pathway | Translation of genes involved in cell proliferation, cell differentiation, apoptosis |
[ |
|
| Unfolded protein response in ER stress | Escaping cell death in cancers |
[ |
|
| Regulates cell cycle progression from G1 to S phase | Biomarker for cell transformation |
[ |
|
| Involved in SUMOylation of topioisomerase II-α and the p150/importin β/RANBP2 pathway | Lung cancer and myelomocytic leukemia |
[ |
Average Clustering coefficients of the PCa modules at first hierarchical level.
| Sl. No. | Modules | Most enriched function | Avg. Clustering coefficient | Corrected |
|---|---|---|---|---|
| 1. | C2 | RNA mediated gene silencing | 0.114 | 2.07E − 07 |
| 2. | C3 | Unfolded protein folding | 0.209 | 4.12E − 16 |
| 3. | C4 | ATP/nucleotide binding | 0.171 | 2.64E − 14 |
| 4. | C5 | MRNA transport | 0.165 | 2.25E − 15 |
| 5. | C6 | Transcription initiation | 0.374 | 2.68E − 12 |
| 6. | C7 | Endoplasmic reticulum membrane proteins | 0.094 | 0.019 |
| 7. | C8 | Endocytosis | 0.14 | 2.67E − 09 |
| 8. | C9 | Mitocondrial proteins | 0.124 | 6.75E − 33 |
| 9. | C10 | Proteosome | 0.182 | 1.02E − 16 |
| 10. | C11 | Ubiquitin protein ligase activity | 0.107 | 1.13E − 10 |
| 11. | C12 | Ribonucleoprotein | 0.392 | 7.50E − 104 |
| 12. | C13 | Transcription regulation | 0.218 | 6.11E − 74 |
| 13. | C14 | Transmembrane helix | 0.096 | 4.07E − 04 |
| 14. | C15 | DNA repair | 0.31 | 6.61E − 08 |
Figure 4Identification of modular hubs. (A) In the primary PCa network and the modules at first Hierarchical level with within module Z score and their participation coefficients P. (B) Identification of modular hubs among 19 key regulators. (C) Participation coefficient P vs degree k in PCa primary network and the modules at first hierarchical level.
Figure 5Rich club analysis of PCa PPI network and the communities upto the motif level.
Figure 6(A) Rich formation in C8, C10 and C15 in first hierarchal level of PCa. (B) Degree maximum and minimum degrees of rich club forming hubs.